Aetiology and prevalence of subclinical mastitis in dairy herds in peri-urban areas of Kigali in Rwanda

被引:0
作者
Jean Baptiste Ndahetuye
Ylva Persson
Ann-Kristin Nyman
Michael Tukei
Martin Patrick Ongol
Renée Båge
机构
[1] Swedish University of Agricultural Sciences (SLU),Reproduction, Department of Clinical Sciences
[2] University of Rwanda,College of Agriculture, Animal Sciences and Veterinary Medicine
[3] National Veterinary Institute,undefined
[4] Växa Sverige,undefined
来源
Tropical Animal Health and Production | 2019年 / 51卷
关键词
Beta-lactamase production; Risk factors; California Mastitis Test; Staphylococci;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this cross-sectional study was to evaluate the prevalence of subclinical mastitis (SCM) and associated risk factors in dairy cows in peri-urban areas of Kigali, Rwanda, and identify causative udder pathogens. A sample of 256 cows from 25 herds was screened with the California Mastitis Test (CMT), and udder quarters with CMT score ≥ 3 (scale 1–5) were milk sampled for culture and final bacteriological identification with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). All resultant staphylococci species were tested for beta-lactamase production with the clover leaf method. In parallel, herd bulk milk somatic cell count (SCC) of each herd was analysed using a portable device, the DeLaval cell counter. The prevalence of SCM was 43.1% at quarter level and 76.2% at cow level based on CMT test. Multiparous, Holstein cows were 2.50 (C.I = 1.32–4.71) and 10.08 (C.I = 1.54–66.13) times more likely to contract SCM infection than primiparous animals or cows of other breeds, respectively. The median and mean SCC of all herds were 1108 × 103 cells/mL and 1179 × 103 cells/mL, respectively. The most prevalent pathogens were non-aureus staphylococci (NAS; 40.2%) followed by Staphylococcus aureus (22%) and less prevalent pathogens (6%). Samples with no growth or contamination constituted 30.4% and 1.4% of the diagnoses, respectively. The most prevalent species within NAS were S. epidermidis (38.2%) followed by S. sciuri (19.5%), S. chromogenes (9.8%), and nine less prevalent NAS species (32.5%). Out of 209 staphylococci isolates, 77% exhibited beta-lactamase production. The study shows that there is high prevalence of SCM and high herd bulk milk SCC in herds in Kigali, indicating udder health problems in dairy cows. Additionally, beta-lactamase production among staphylococci species was common. Improved milking hygiene and application of biosecurity measures, or a complete mastitis control plan, is required to lower the prevalence of SCM and minimize the spread of pathogens among dairy cows.
引用
收藏
页码:2037 / 2044
页数:7
相关论文
共 178 条
[1]  
Abebe R(2016)Bovine mastitis: Prevalence, risk factors and isolation of BMC Veterinary Research 12 270-105
[2]  
Hatiya H(2014) in dairy herds at Hawassa milk shed, South Ethiopia Tropical Animal Health and Production 46 99-1895
[3]  
Abera M(2006)Prevalence of subclinical mastitis in dairy farms in urban and peri-urban areas of Kampala, Uganda Journal of Dairy Science 89 1877-127
[4]  
Megersa B(2014)Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Irish Veterinary Journal 67 12-572
[5]  
Asmare K(1979) mastitis Journal of Dairy Science 62 119-4883
[6]  
Abrahmsén M(2014)Characterization of coagulase negative staphylococci from cases of subclinical mastitis in dairy cattle in Kampala, Uganda The Veterinary Journal 202 566-797
[7]  
Persson Y(2017)Economic Losses from and the National Research Program on Mastitis in the United States Journal of Dairy Science 100 4868-259
[8]  
Kanyima B(1997)Mastitis in Dairy Heifers: Prevalence and Risk Factors Journal of Advanced Nursing 26 790-50
[9]  
Båge R(2001)Associations between pathogen-specific cases of subclinical mastitis and milk yield, quality, protein composition, and cheese-making traits in dairy cows Advanced Drug Delivery Reviews 50 245-6
[10]  
Barkema HW(1995)Sampling hard to reach populations Journal of Dairy Research 62 39-305